Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03581864
Other study ID # 0002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2006
Est. completion date May 1, 2018

Study information

Verified date June 2018
Source Medical University of Lublin
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose: To assess long-term outcomes of implantation of black diaphragmintraocular lens (BD IOL) in postraumatic aniridia and aphakia due to eye rupture.

METHODS: This is retrospective consecutive case series of 14 eyes with post-traumatic complete aniridia and aphakia treated withscleral fixation of BD IOL with. Measurements included ophthalmological comorbidities, best corrected visual acuity (BCVA), complications, and postoperative interventions. The average postoperative follow-up period was 36 months.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date May 1, 2018
Est. primary completion date December 31, 2017
Accepts healthy volunteers No
Gender All
Age group 25 Years to 79 Years
Eligibility Inclusion Criteria:

post-traumatic complete aniridia and aphakia

Exclusion Criteria:

active ocluar inflammation or infection

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Poland General Department of Ophthalmology in Lublin Lublin

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Lublin

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Best-corrected visual acuity The visual acuity measurement with ETDRS chart 10 to 120 months
Primary The slit lamp examination The anterior segment of the eye and eye fundus were examined. 10 to 120 months
Primary The intrraocular pressure measurement The procedure was performed with the Goldman applanation tonometer. 10 to 120 months
Primary The medical history Coexisting eye diseases and post-operative complications were noted. 10 to 120 months
See also
  Status Clinical Trial Phase
Completed NCT00758108 - Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Not yet recruiting NCT06412718 - Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Recruiting NCT05400590 - Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients
Recruiting NCT05044598 - RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy Phase 1/Phase 2
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT00001161 - Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Recruiting NCT05954403 - National Cohort on Congenital Defects of the Eye
Completed NCT02647359 - Study of Ataluren in Participants With Nonsense Mutation Aniridia Phase 2
Recruiting NCT05562115 - Proteomic Study of Tears From Patients With a PAX6 Mutation N/A
Completed NCT00265590 - Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia N/A
Withdrawn NCT04117880 - A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia Phase 2
Active, not recruiting NCT00503893 - Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
Completed NCT01644552 - Positive Angle Kappa
Completed NCT00812708 - Clinical Evaluation of Morcher Artificial Iris Diaphragms N/A